Related references
Note: Only part of the references are listed.α-Synuclein strains cause distinct synucleinopathies after local and systemic administration
W. Peelaerts et al.
NATURE (2015)
Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration
Katrina L. Paumier et al.
NEUROBIOLOGY OF DISEASE (2015)
The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells
Mohamed-Bilal Fares et al.
HUMAN MOLECULAR GENETICS (2014)
The H50Q Mutation Enhances α-Synuclein Aggregation, Secretion, and Toxicity
Ossama Khalaf et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Brain Injection of α-Synuclein Induces Multiple Proteinopathies, Gliosis, and a Neuronal Injury Marker
Amanda N. Sacino et al.
JOURNAL OF NEUROSCIENCE (2014)
Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice
Amanda N. Sacino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Phosphorylation Modulates Clearance of Alpha-Synuclein Inclusions in a Yeast Model of Parkinson's Disease
Sandra Tenreiro et al.
PLOS GENETICS (2014)
Pathological alpha-synuclein propagates through neural networks
Masami Masuda-Suzukake et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Alpha-synuclein spreading in M83 mice brain revealed by detection of pathological α-synuclein by enhanced ELISA
Dominique Betemps et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
David J. Irwin et al.
NATURE REVIEWS NEUROSCIENCE (2013)
The many faces of alpha-synuclein: from structure and toxicity to therapeutic target
Hilal A. Lashuel et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Induction of CNS alpha-synuclein pathology by fibrillar and non- amyloidogenic recombinant alpha-synuclein
Amanda N. Sacino et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2013)
Characterization of Semisynthetic and Naturally Nα-Acetylated α-Synuclein in Vitro and in Intact Cells IMPLICATIONS FOR AGGREGATION AND CELLULAR PROPERTIES OF α-SYNUCLEIN
Bruno Fauvet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice
Kelvin C. Luk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Mimicking Phosphorylation at Serine 87 Inhibits the Aggregation of Human α-Synuclein and Protects against Its Toxicity in a Rat Model of Parkinson's Disease
Abid Oueslati et al.
JOURNAL OF NEUROSCIENCE (2012)
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
Kelvin C. Luk et al.
SCIENCE (2012)
Functional Alterations to the Nigrostriatal System in Mice Lacking All Three Members of the Synuclein Family
Sabina Anwar et al.
JOURNAL OF NEUROSCIENCE (2011)
Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death
Laura A. Volpicelli-Daley et al.
NEURON (2011)
Confocal Fluorescence Anisotropy and FRAP Imaging of α-Synuclein Amyloid Aggregates in Living Cells
M. Julia Roberti et al.
PLOS ONE (2011)
The Ability of Rodent Islet Amyloid Polypeptide To Inhibit Amyloid Formation by Human Islet Amyloid Polypeptide Has Important Implications for the Mechanism of Amyloid Formation and the Design of Inhibitors
Ping Cao et al.
BIOCHEMISTRY (2010)
Suppression of IAPP fibrillation at anionic lipid membranes via IAPP-derived amyloid inhibitors and insulin
Daniel Sellin et al.
BIOPHYSICAL CHEMISTRY (2010)
Entacapone and Tolcapone, Two Catechol O-Methyltransferase Inhibitors, Block Fibril Formation of α-Synuclein and β-Amyloid and Protect against Amyloid-induced Toxicity
Saviana Di Giovanni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
A Monomeric Photoconvertible Fluorescent Protein for Imaging of Dynamic Protein Localization
Hiofan Hoi et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Phosphorylation at S87 Is Enhanced in Synucleinopathies, Inhibits α-Synuclein Oligomerization, and Influences Synuclein-Membrane Interactions
Katerina E. Paleologou et al.
JOURNAL OF NEUROSCIENCE (2010)
Genetic Animal Models of Parkinson's Disease
Ted M. Dawson et al.
NEURON (2010)
α-Synuclein and neuronal cell death
Mark R. Cookson
MOLECULAR NEURODEGENERATION (2009)
A bright and photostable photoconvertible fluorescent protein
Sean A. McKinney et al.
NATURE METHODS (2009)
Accumulation and clearance of α-synuclein aggregates demonstrated by time-lapse imaging
Felipe Opazo et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Aggregates Assembled From Overexpression of Wild-Type α-Synuclein are not Toxic to Human Neuronal Cells
Li-wen Ko et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
β-synuclein modulates α-synuclein neurotoxicity by reducing α-synuclein protein expression
Yuxin Fan et al.
HUMAN MOLECULAR GENETICS (2006)
Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human α-synuclein (1-120):: Implications for Lewy body disorders
GK Tofaris et al.
JOURNAL OF NEUROSCIENCE (2006)
Mice lacking alpha-synuclein are resistant to mitochondrial toxins
P Klivenyi et al.
NEUROBIOLOGY OF DISEASE (2006)
Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background
DE Cabin et al.
NEUROBIOLOGY OF AGING (2005)
Aggresomes formed by α-synuclein and synphilin-1 are cytoprotective
M Tanaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of γ-synuclein, α-synuclein and double α/γ-synuclein null mutant mice
DC Robertson et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Double-knockout mice for α- and β-synucleins:: Effect on synaptic functions
S Chandra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
β-synuclein inhibits formation of α-synuclein protofibrils:: A possible therapeutic strategy against Parkinson's disease
JY Park et al.
BIOCHEMISTRY (2003)
Parkin protects against the toxicity associated with mutant α-synuclein:: Proteasome dysfunction selectively affects catecholaminergic neurons
L Petrucelli et al.
NEURON (2002)
Phosphorylated α-synuclein is ubiquitinated in α-synucleinopathy lesions
M Hasegawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro
MM Sousa et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Biophysical properties of the synucleins and their propensities to fibrillate -: Inhibition of α-synuclein assembly by β- and γ-synucleins
VN Uversky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Formation and removal of α-synuclein aggregates in cells exposed to mitochondrial inhibitors
HJ Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
α-Synuclein is phosphorylated in synucleinopathy lesions
H Fujiwara et al.
NATURE CELL BIOLOGY (2002)
Differential localization of alpha-, beta- and gamma-synucleins in the rat CNS
JY Li et al.
NEUROSCIENCE (2002)
α-Synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome
GK Tofaris et al.
FEBS LETTERS (2001)
β-synuclein inhibits α-synuclein aggregation:: A possible role as an anti-parkinsonian factor
M Hashimoto et al.
NEURON (2001)
Trans-suppression of misfolding in an amyloid disease
P Hammarström et al.
SCIENCE (2001)
Deletion of the alpha-synuclein locus in a subpopulation of C57BL/6J inbred mice
Christian G. Specht et al.
BMC NEUROSCIENCE (2001)
alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons
PJ McLean et al.
NEUROSCIENCE (2001)
Expression of mutant α-synuclein causes increased susceptibility to dopamine toxicity
SJ Tabrizi et al.
HUMAN MOLECULAR GENETICS (2000)
Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse α-synuclein
JC Rochet et al.
BIOCHEMISTRY (2000)
A Drosophila model of Parkinson's disease
MB Feany et al.
NATURE (2000)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)
Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system
A Abeliovich et al.
NEURON (2000)
Share Paper
